CA125 is Superior to CA19-9 in Predicting the Resectability of Pancreatic Cancer

Guopei Luo,Zhiwen Xiao,Jiang Long,Zuqiang Liu,Liang Liu,Chen Liu,Jin Xu,Quanxing Ni,Xianjun Yu

DOI: https://doi.org/10.1007/s11605-013-2389-9

2013-01-01

Journal of Gastrointestinal Surgery

Abstract:Although carbohydrate antigen 19-9 (CA19-9) has been reported as a biomarker to predict the resectability of pancreatic cancer, several limitations have restricted its clinical use.